Nanalysis Scientific (CVE:NSCI) Stock Price Down 12.1% – Time to Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s stock price dropped 12.1% during mid-day trading on Monday . The company traded as low as C$0.15 and last traded at C$0.15. Approximately 274,264 shares were traded during trading, an increase of 203% from the average daily volume of 90,466 shares. The stock had previously closed at C$0.17.

Nanalysis Scientific Price Performance

The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The business has a 50-day simple moving average of C$0.18 and a 200 day simple moving average of C$0.22. The firm has a market cap of C$17.22 million, a P/E ratio of -1.50 and a beta of -0.91.

Nanalysis Scientific Company Profile

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Read More

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.